Literature DB >> 1309889

Characterization of early pathogenic effects after experimental infection of calves with bovine immunodeficiency-like virus.

S Carpenter1, L D Miller, S Alexandersen, C A Whetstone, M J VanDerMaaten, B Viuff, Y Wannemuehler, J M Miller, J A Roth.   

Abstract

The early pathogenic effects of bovine immunodeficiency-like virus (BIV) were studied in calves experimentally inoculated with BIV. All animals inoculated with BIV R29-infected cells seroconverted by 6 weeks postinoculation, and BIV was recoverable from each animal at 2 weeks postinoculation. However, levels of BIV replication in vivo appeared to be low. In situ hybridization studies indicated that during peak periods of viral replication in vivo, less than 0.03% of peripheral blood mononuclear cells were expressing detectable levels of viral RNA. Moreover, the levels of viral RNA in these cells in vivo were less than 1/10 the levels observed in persistently infected cells in vitro. BIV-inoculated calves had significantly higher numbers of circulating lymphocytes, and follicular hyperplasia was observed in lymph nodes, hemal nodes, and spleen. The histopathological changes observed in BIV-infected calves were similar to changes found early after infection with the immunosuppressive lentiviruses, including human immunodeficiency virus type 1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309889      PMCID: PMC240811     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.

Authors:  S Alexandersen; S Carpenter
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Ultrastructural studies of a visna-like syncytia-producing virus from cattle with lymphocytosis.

Authors:  A D Boothe; A J Van der Maaten
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

3.  Isolation, immunodiffusion, immunofluorescence, and electron microscopy of a syncytial virus of lymphosarcomatous and apparently normal cattle.

Authors:  W A Malmquist; M J Van der Maaten; A D Boothe
Journal:  Cancer Res       Date:  1969-01       Impact factor: 12.701

4.  Pathology of equine infectious anemia. Proposed classification of pathological types of disease.

Authors:  S Konno; H Yamamoto
Journal:  Cornell Vet       Date:  1970-07

Review 5.  Functional anatomy of germinal centers.

Authors:  P Nieuwenhuis; D Opstelten
Journal:  Am J Anat       Date:  1984-07

6.  Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies.

Authors:  A Orrego; C J Issel; R C Montelaro; W V Adams
Journal:  Am J Vet Res       Date:  1982-09       Impact factor: 1.156

7.  Comparative pathologic, immunologic, and clinical responses produced by selected agents of the bovine mucosal disease-virus diarrhea complex.

Authors:  D E Tyler; F K Ramsey
Journal:  Am J Vet Res       Date:  1965-07       Impact factor: 1.156

8.  A western blot assay for the detection of antibodies to bovine immunodeficiency-like virus in experimentally inoculated cattle, sheep, and goats.

Authors:  C A Whetstone; M J VanDerMaaten; J M Miller
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Methods for detection and frequency of contamination of fetal calf serum with bovine viral diarrhea virus and antibodies against bovine viral diarrhea virus.

Authors:  S R Bolin; P J Matthews; J F Ridpath
Journal:  J Vet Diagn Invest       Date:  1991-07       Impact factor: 1.279

10.  Effects of bovine viral diarrhea virus infection on bovine polymorphonuclear leukocyte function.

Authors:  J A Roth; M L Kaeberle; R W Griffith
Journal:  Am J Vet Res       Date:  1981-02       Impact factor: 1.156

View more
  26 in total

1.  Thermal inactivation of bovine immunodeficiency virus.

Authors:  E C Moore; D Keil; K S Coats
Journal:  Appl Environ Microbiol       Date:  1996-11       Impact factor: 4.792

2.  Size variation within the second hypervariable region of the surface envelope gene of the bovine lentivirus BIV in experimentally and naturally infected cattle.

Authors:  D L Suarez; C A Whetstone
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Differentiation of two bovine lentiviruses by a monoclonal antibody on the basis of epitope specificity.

Authors:  L Zheng; S Zhang; C Wood; S Kapil; G E Wilcox; T A Loughin; H C Minocha
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  Haematological and lymphocyte subset analyses in sheep inoculated with bovine immunodeficiency-like virus.

Authors:  R M Jacobs; H E Smith; C A Whetstone; D L Suarez; B Jefferson; V E Valli
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

5.  Immunological characterization of the gag gene products of bovine immunodeficiency virus.

Authors:  J K Battles; M Y Hu; L Rasmussen; G J Tobin; M A Gonda
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  Characterization of the Jembrana disease virus tat gene and the cis- and trans-regulatory elements in its long terminal repeats.

Authors:  H Chen; G Wilcox; G Kertayadnya; C Wood
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Isolation and characterization of new wild-type isolates of bovine lentivirus.

Authors:  D L Suarez; M J VanDerMaaten; C Wood; C A Whetstone
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Prevalence of bovine immunodeficiency-like virus in bulls as determined by serology and proviral detection.

Authors:  R M Jacobs; B J Jefferson; D L Suarez
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

9.  Bovine immunodeficiency virus: a lentiviral infection.

Authors:  Sandeep Bhatia; S S Patil; R Sood
Journal:  Indian J Virol       Date:  2013-09-27

10.  Bovine immunodeficiency virus expression in vitro is reduced in the presence of beta-chemokines, MIP-1alpha, MIP-1beta and RANTES.

Authors:  S M Wright; A Mleczko; K S Coats
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.